Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L F Massuger

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
The Lancet. Oncology|November 30, 2011
Pelvic inflammatory disease and ovarian cancerR van de Laar, L F Massuger
Lancet (London, England)|July 25, 2000
Needless treatment for presumed malignancyC M Thomas, L F Massuger, H M Merkus
European Radiology|February 9, 2000
The role of MR imaging in invasive cervical carcinomaE A Boss, J O Barentsz, L F Massuger, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 7, 2015
External validation of the paediatric risk of malignancy indexA J Hermans, K B Kluivers, L F Massuger, et al.
Gynecologic Oncology|December 22, 1999
Cytologic examination to detect clear cell adenocarcinoma of the vagina or cervixA G Hanselaar, E A Boss, L F Massuger, et al.
European Journal of Radiology|October 27, 1998
Borderline ovarian malignancy: ultrasound and fast dynamic MR findingsP B Van Vierzen, L F Massuger, S H Ruys, et al.
Cancer|May 12, 1998
1H-magnetic resonance spectroscopy: a new technique to discriminate benign from malignant ovarian tumorsL F Massuger, P B van Vierzen, U Engelke, et al.
Clinical Radiology|April 7, 1998
Fast dynamic contrast enhanced MR imaging of cervical carcinomaP B Van Vierzen, L F Massuger, S H Ruys, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 20, 1991
Detection and localization of ovarian cancer with radiolabeled monoclonal antibodiesL F Massuger, P Kenemans, R A Claessens, et al.
Gynecologic Oncology|March 4, 1999
Uterine malignant leiomyoblastoma (epithelioid leiomyosarcoma) during pregnancyR L Bekkers, L F Massuger, P P Berg, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
The Lancet. Oncology|November 30, 2011
Pelvic inflammatory disease and ovarian cancerR van de Laar, L F Massuger
Lancet (London, England)|July 25, 2000
Needless treatment for presumed malignancyC M Thomas, L F Massuger, H M Merkus
European Radiology|February 9, 2000
The role of MR imaging in invasive cervical carcinomaE A Boss, J O Barentsz, L F Massuger, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 7, 2015
External validation of the paediatric risk of malignancy indexA J Hermans, K B Kluivers, L F Massuger, et al.
Gynecologic Oncology|December 22, 1999
Cytologic examination to detect clear cell adenocarcinoma of the vagina or cervixA G Hanselaar, E A Boss, L F Massuger, et al.
European Journal of Radiology|October 27, 1998
Borderline ovarian malignancy: ultrasound and fast dynamic MR findingsP B Van Vierzen, L F Massuger, S H Ruys, et al.
Cancer|May 12, 1998
1H-magnetic resonance spectroscopy: a new technique to discriminate benign from malignant ovarian tumorsL F Massuger, P B van Vierzen, U Engelke, et al.
Clinical Radiology|April 7, 1998
Fast dynamic contrast enhanced MR imaging of cervical carcinomaP B Van Vierzen, L F Massuger, S H Ruys, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 20, 1991
Detection and localization of ovarian cancer with radiolabeled monoclonal antibodiesL F Massuger, P Kenemans, R A Claessens, et al.
Gynecologic Oncology|March 4, 1999
Uterine malignant leiomyoblastoma (epithelioid leiomyosarcoma) during pregnancyR L Bekkers, L F Massuger, P P Berg, et al.
Pageof 6